These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12604879)

  • 21. Cellular and ionic basis for T-wave alternans under long-QT conditions.
    Shimizu W; Antzelevitch C
    Circulation; 1999 Mar; 99(11):1499-507. PubMed ID: 10086976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of disopyramide and mexiletine on the terminal repolarization process of the in situ heart assessed using the halothane-anesthetized in vivo canine model.
    Yoshida H; Sugiyama A; Satoh Y; Ishida Y; Kugiyama K; Hashimoto K
    Circ J; 2002 Sep; 66(9):857-62. PubMed ID: 12224826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
    Sicouri S; Timothy KW; Zygmunt AC; Glass A; Goodrow RJ; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2007 May; 4(5):638-47. PubMed ID: 17467634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
    Priori SG; Cantù F; Schwartz PJ
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repolarization heterogeneity and rate dependency in a canine rapid pacing model of heart failure.
    Lux RL; Gettes LS
    J Electrocardiol; 2011; 44(6):730-5. PubMed ID: 21924432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epicardial but not endocardial premature stimulation initiates ventricular tachyarrhythmia in canine in vitro model of long QT syndrome.
    Ueda N; Zipes DP; Wu J
    Heart Rhythm; 2004 Dec; 1(6):684-94. PubMed ID: 15851240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coupling interval-related effects of class I antiarrhythmic drugs, mexiletine, cibenzoline and disopyramide, on ventricular activation in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    Jpn J Pharmacol; 1991 Dec; 57(4):463-72. PubMed ID: 1803064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The peak-to-end of the T wave in the limb ECG leads reflects total spatial rather than transmural dispersion of ventricular repolarization in an anthopleurin-A model of prolonged QT interval.
    Izumi D; Chinushi M; Iijima K; Furushima H; Hosaka Y; Hasegawa K; Aizawa Y
    Heart Rhythm; 2012 May; 9(5):796-803. PubMed ID: 22123313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall.
    Yan GX; Wu Y; Liu T; Wang J; Marinchak RA; Kowey PR
    Circulation; 2001 Jun; 103(23):2851-6. PubMed ID: 11401944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indications for mexiletine in the new ESC guidelines and beyond.
    Vamos M; Zsigmond EJ; Hohnloser SH
    Expert Opin Pharmacother; 2023; 24(12):1403-1407. PubMed ID: 37306465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A molecular basis for the therapy of the long QT syndrome.
    Priori SG; Napolitano C; Schwartz PJ
    Arch Mal Coeur Vaiss; 1996 Sep; 89(9):1185-7. PubMed ID: 8952843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
    Shimizu W; Antzelevitch C
    Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between the effective refractory period and activation-recovery interval calculated from the intracardiac unipolar electrogram of humans with and without dl-sotalol treatment.
    Chinushi M; Tagawa M; Kasai H; Washizuka T; Abe A; Furushima H; Aizawa Y
    Jpn Circ J; 2001 Aug; 65(8):702-6. PubMed ID: 11502045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of regional dispersion of repolarization and T-peak to T-end interval by the right and left stellate ganglia.
    Vaseghi M; Yamakawa K; Sinha A; So EL; Zhou W; Ajijola OA; Lux RL; Laks M; Shivkumar K; Mahajan A
    Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1020-30. PubMed ID: 23893168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization.
    Yamauchi M; Watanabe E; Yasui K; Takeuchi H; Terasawa T; Sawada K; Hishida H; Kodama I
    Int J Cardiol; 2005 Aug; 103(1):92-7. PubMed ID: 16061129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bepridil Inhibits Premature Ventricular Complexes Induced by Cardio-Sympathetic Nerve Stimulation in a Canine Experimental Model.
    Saitoh O; Watanabe J; Sugai A; Oikawa A; Sugai M; Chinushi M
    Int Heart J; 2020 Mar; 61(2):338-346. PubMed ID: 32173709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldosterone blockade attenuates development of an electrophysiological substrate associated with ventricular tachyarrhythmias in heart failure.
    Stambler BS; Laurita KR; Shroff SC; Hoeker G; Martovitz NL
    Heart Rhythm; 2009 Jun; 6(6):776-83. PubMed ID: 19427273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.